GT BiopharmaGTBP

13F holders, Q2 2026 (June 30)
59holders +17
20new positions
5sold out
$0.49avg. 13F price*

At the end of Q2 2026, 59 institutions reported holding GT Biopharma Inc. (GTBP) in their 13F filings, up 17 from Q1 2026. 20 opened new positions and 5 sold out. The largest holders were Vanguard Capital Management LLC ($184K), Geode Capital Management, LLC ($131K) and Vanguard Fiduciary Trust Co. ($111K).

Company
GT Biopharma Inc.
CUSIP
36254L308
Latest filing quarter
Q2 2026

History

Number of 13F holders

0204060 Q1 2024: 16Q1 2024Q2 2024: 17Q2 2024Q3 2024: 16Q3 2024Q4 2024: 18Q4 2024Q1 2025: 20Q1 2025Q2 2025: 21Q2 2025Q3 2025: 21Q3 2025Q4 2025: 38Q4 2025Q1 2026: 42Q1 2026Q2 2026: 59Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions20$327K
Exits5$51K

All 13F filers, Q1 2026 → Q2 2026: 716,641 shares bought and 293,148 shares sold, net +423,493 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 59 holders

Vanguard Capital Management LLC 0.00% Reduce -16.7% 376,399 $184K
Geode Capital Management, LLC 0.00% Reduce -9.4% 266,788 $131K
Vanguard Fiduciary Trust Co. 0.00% No change 225,938 $111K
HRT Financial LP 0.00% New 107,140 $52K
Everhart Financial Group, Inc. 0.00% New 100,000 $49K
Arax Advisory Partners 0.00% No change 93,627 $46K
Opal Wealth Advisors, LLC 0.01% New 81,811 $40K
Northern Trust Corp. 0.00% New 75,461 $37K
49 Wealth Management, LLC 0.01% New 64,000 $31K
Alongside, LLC 0.01% — 64,000 $31K
Cetera Investment Advisers 0.00% New 55,936 $27K
SeaCrest Wealth Management, LLC 0.00% Add +0.2% 50,100 $25K
Kitching Partners, LLC 0.02% New 50,000 $24K
PNC Financial Services Group, Inc. 0.00% New 40,000 $20K
Osaic Holdings, Inc. 0.00% Add +83.3% 38,500 $19K
LPL Financial LLC 0.00% Add +19.7% 36,379 $18K
Morgan Stanley 0.00% Add +36.0% 22,573 $11K
Keel Point, LLC 0.00% No change 20,768 $10K
Integrated Wealth Concepts LLC 0.00% No change 20,006 $10K
Private Wealth Management Group, LLC 0.00% No change 20,000 $10K
Sagespring Wealth Partners, LLC 0.00% New 20,000 $10K
Corient Private Wealth LP 0.00% New 20,000 $10K
StoneX Group Inc. 0.00% Add +57.6% 23,258 $9K
Caitlin John, LLC 0.00% No change 16,500 $8K
Coston, McIsaac & Partners 0.00% No change 17,092 $8K
Wells Fargo & Company 0.00% Reduce -0.3% 15,986 $8K
Tempus Wealth Planning, LLC 0.00% New 15,000 $7K
Am Investment Strategies LLC 0.00% No change 15,000 $7K
Two Sigma Securities, LLC 0.00% Reduce -57.9% 13,386 $7K
Prospera Financial Services Inc 0.00% Add +4.2% 12,500 $6K
Verdence Capital Advisors LLC 0.00% No change 12,000 $6K
LaSalle St. Investment Advisors, LLC 0.00% No change 11,000 $5K
Mayflower Financial Advisors, LLC 0.00% New 11,000 $5K
Parsons Capital Management Inc. 0.00% No change 10,900 $5K
Koss-Olinger Consulting, LLC 0.00% New 10,000 $5K
North Star Asset Management Inc. 0.00% New 10,000 $5K
BlackRock, Inc. 0.00% Reduce -1.1% 8,312 $4K
Royal Bank of Canada 0.00% Add +5931.8% 7,600 $4K
HBK Sorce Advisory LLC 0.00% No change 10,000 $3K
Atlantic Union Bankshares Corp 0.00% New 5,351 $3K
Allworth Financial LP 0.00% No change 4,501 $2K
NFSG Corp 0.00% No change 3,750 $2K
MassMutual Private Wealth & Trust, FSB 0.00% No change 3,000 $1K
Farther Finance Advisors, LLC 0.00% No change 3,000 $1K
West Financial Advisors, LLC 0.00% No change 2,500 $1K
Stone House Investment Management, LLC 0.00% Add +63.3% 2,043 $1K
Tower Research Capital LLC (TRC) 0.00% Reduce -0.1% 1,696 $831
Triumph Capital Management 0.00% No change 1,655 $810
Barclays PLC 0.00% New 1,441 $706
Jones Financial Companies LLLP 0.00% New 1,500 $645
Reyes Financial Architecture, Inc. 0.00% New 625 $306
Harbour Investments, Inc. 0.00% New 500 $245
Global Retirement Partners, LLC 0.00% — 500 $245
Hilltop National Bank 0.00% No change 100 $49
IFG Advisory, LLC 0.00% New 33 $16
BNP Paribas Financial Markets 0.00% Reduce -62.5% 6 $3
UBS Group AG 0.00% Reduce -100.0% 2 $1
JPMorgan Chase & Co. 0.00% No change 1 $0
SBI Securities Co., Ltd. 0.00% No change 1 $0

"% of holder's portfolio" is GTBP's weight in each manager's 13F, not the share of GT Biopharma Inc. the manager owns.